Kevin A. Nash

4.4k total citations · 3 hit papers
27 papers, 3.3k citations indexed

About

Kevin A. Nash is a scholar working on Epidemiology, Infectious Diseases and Small Animals. According to data from OpenAlex, Kevin A. Nash has authored 27 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 16 papers in Infectious Diseases and 6 papers in Small Animals. Recurrent topics in Kevin A. Nash's work include Mycobacterium research and diagnosis (20 papers), Tuberculosis Research and Epidemiology (15 papers) and Infectious Diseases and Mycology (6 papers). Kevin A. Nash is often cited by papers focused on Mycobacterium research and diagnosis (20 papers), Tuberculosis Research and Epidemiology (15 papers) and Infectious Diseases and Mycology (6 papers). Kevin A. Nash collaborates with scholars based in United States, France and Australia. Kevin A. Nash's co-authors include Abdul Hafeez, Susan Hou, Richard J. Wallace, Barbara A. Brown‐Elliott, Clark B. Inderlied, Nadya Andini, Yansheng Zhang, Yansheng Zhang, Adriana E. Rosato and Elena Iakhiaeva and has published in prestigious journals such as Clinical Microbiology Reviews, Journal of Clinical Microbiology and Journal of the American Society of Nephrology.

In The Last Decade

Kevin A. Nash

27 papers receiving 3.2k citations

Hit Papers

Hospital-acquired renal i... 2002 2026 2010 2018 2002 2009 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hospital-acquired renal insufficiency
    2002 1.5k citations Kevin A. Nash, Abdul Hafeez et al. American Journal of Kidney Diseases profile →
  2. A Novel Gene, erm (41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae
    2009 481 citations Kevin A. Nash, Barbara A. Brown‐Elliott et al. Antimicrobial Agents and Chemotherapy profile →
  3. Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
    2012 379 citations Barbara A. Brown‐Elliott, Kevin A. Nash et al. Clinical Microbiology Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin A. Nash United States 18 1.7k 1.3k 1.2k 826 379 27 3.3k
Lluı́s Castells Spain 32 3.0k 1.8× 275 0.2× 389 0.3× 100 0.1× 1.9k 5.0× 147 5.4k
Ali J. Olyaei United States 27 1.8k 1.1× 211 0.2× 1.7k 1.4× 157 0.2× 833 2.2× 70 3.9k
Chih‐Wei Yang Taiwan 30 306 0.2× 796 0.6× 259 0.2× 165 0.2× 369 1.0× 95 2.4k
Helmut Ostermann Germany 36 1.4k 0.9× 71 0.1× 808 0.7× 69 0.1× 529 1.4× 134 4.1k
Ben van der Hoven Netherlands 19 653 0.4× 261 0.2× 511 0.4× 63 0.1× 243 0.6× 48 1.6k
Herwig‐Ulf Meier‐Kriesche United States 35 955 0.6× 653 0.5× 580 0.5× 25 0.0× 2.3k 6.2× 73 5.7k
Nattachai Srisawat Thailand 29 606 0.4× 1.4k 1.1× 315 0.3× 12 0.0× 437 1.2× 149 2.6k
James Spalding United States 24 546 0.3× 81 0.1× 786 0.7× 56 0.1× 266 0.7× 58 2.3k
Adam Linder Sweden 32 1.4k 0.8× 283 0.2× 352 0.3× 13 0.0× 388 1.0× 100 2.8k
Michael Meisner Germany 29 2.6k 1.6× 231 0.2× 214 0.2× 21 0.0× 891 2.4× 49 3.8k

Countries citing papers authored by Kevin A. Nash

Since Specialization
Citations

This map shows the geographic impact of Kevin A. Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Nash more than expected).

Fields of papers citing papers by Kevin A. Nash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Nash. The network helps show where Kevin A. Nash may publish in the future.

Co-authorship network of co-authors of Kevin A. Nash

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Nash. A scholar is included among the top collaborators of Kevin A. Nash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Nash. Kevin A. Nash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nash, Kevin A.. (2016). Multidrug Resistance in Mycobacteria. Current Clinical Microbiology Reports. 3(1). 53–61. 2 indexed citations
2.
Brown‐Elliott, Barbara A., Sruthi Vasireddy, Ravikiran Vasireddy, et al.. (2015). Utility of Sequencing the erm (41) Gene in Isolates of Mycobacterium abscessus subsp. abscessus with Low and Intermediate Clarithromycin MICs. Journal of Clinical Microbiology. 53(4). 1211–1215. 135 indexed citations
3.
Nash, Kevin A., Helty Adisetiyo, Mengmeng Liang, et al.. (2014). CAF-Secreted Annexin A1 Induces Prostate Cancer Cells to Gain Stem Cell–like Features. Molecular Cancer Research. 12(4). 607–621. 53 indexed citations
4.
Brown‐Elliott, Barbara A., Kevin A. Nash, & Richard J. Wallace. (2012). Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria. Clinical Microbiology Reviews. 25(3). 545–582. 379 indexed citations breakdown →
5.
Andini, Nadya & Kevin A. Nash. (2011). Expression of tmRNA in mycobacteria is increased by antimicrobial agents that target the ribosome. FEMS Microbiology Letters. 322(2). 172–179. 15 indexed citations
6.
Nash, Kevin A., Barbara A. Brown‐Elliott, & Richard J. Wallace. (2009). A Novel Gene, erm (41), Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus but Is Absent from Mycobacterium chelonae. Antimicrobial Agents and Chemotherapy. 53(4). 1367–1376. 481 indexed citations breakdown →
7.
Armenian, Saro H., Kevin A. Nash, Neena Kapoor, et al.. (2009). Prospective Monitoring for Invasive Aspergillosis Using Galactomannan and Polymerase Chain Reaction in High Risk Pediatric Patients. Journal of Pediatric Hematology/Oncology. 31(12). 920–926. 39 indexed citations
8.
Nash, Kevin A.. (2008). A Novel Gene, erm(41) , Confers Inducible Macrolide Resistance to Clinical Isolates of Mycobacterium abscessus. 46th Annual Meeting. 1 indexed citations
9.
Nash, Kevin A., et al.. (2008). Icodextrin: an alternative peritoneal dialysis fluid. Expert Opinion on Drug Metabolism & Toxicology. 4(11). 1455–1464. 3 indexed citations
10.
Nash, Kevin A., Nadya Andini, Yansheng Zhang, Barbara A. Brown‐Elliott, & Richard J. Wallace. (2006). Intrinsic Macrolide Resistance in Rapidly Growing Mycobacteria. Antimicrobial Agents and Chemotherapy. 50(10). 3476–3478. 82 indexed citations
11.
12.
Finkelstein, Fredric O., Helen Healy, Ali K. Abu‐Alfa, et al.. (2005). Superiority of Icodextrin Compared with 4.25% Dextrose for Peritoneal Ultrafiltration. Journal of the American Society of Nephrology. 16(2). 546–554. 96 indexed citations
13.
Nash, Kevin A., Yansheng Zhang, Barbara A. Brown‐Elliott, & Richard J. Wallace. (2004). Molecular basis of intrinsic macrolide resistance in clinical isolates of Mycobacterium fortuitum. Journal of Antimicrobial Chemotherapy. 55(2). 170–177. 101 indexed citations
14.
Ohkusu, Kiyofumi, Luiz E. Bermudez, Kevin A. Nash, Rob Roy MacGregor, & Clark B. Inderlied. (2004). Differential Virulence ofMycobacterium aviumStrains Isolated from HIV‐Infected Patients with DisseminatedM. aviumComplex Disease. The Journal of Infectious Diseases. 190(7). 1347–1354. 17 indexed citations
15.
Nash, Kevin A.. (2003). Intrinsic Macrolide Resistance in Mycobacterium smegmatis Is Conferred by a Novel erm Gene, erm (38). Antimicrobial Agents and Chemotherapy. 47(10). 3053–3060. 55 indexed citations
16.
Nash, Kevin A., Abdul Hafeez, & Susan Hou. (2002). Hospital-acquired renal insufficiency. American Journal of Kidney Diseases. 39(5). 930–936. 1467 indexed citations breakdown →
17.
Rosato, Adriana E., et al.. (2001). Inducible Macrolide Resistance in Corynebacterium jeikeium. Antimicrobial Agents and Chemotherapy. 45(7). 1982–1989. 45 indexed citations
18.
Nash, Kevin A., et al.. (1997). Detection of Rifampin Resistance inMycobacterium tuberculosisby Use of a Rapid, Simple, and Specific RNA/RNA Mismatch Assay. The Journal of Infectious Diseases. 176(2). 533–536. 38 indexed citations
19.
20.
Nash, Kevin A. & Clark B. Inderlied. (1995). Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrobial Agents and Chemotherapy. 39(12). 2625–2630. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lluı́s Castells Breakdown of academic impact, for papers by Ali J. Olyaei Breakdown of academic impact, for papers by Chih‐Wei Yang Breakdown of academic impact, for papers by Helmut Ostermann Breakdown of academic impact, for papers by Ben van der Hoven Breakdown of academic impact, for papers by Herwig‐Ulf Meier‐Kriesche Breakdown of academic impact, for papers by Nattachai Srisawat Breakdown of academic impact, for papers by James Spalding Breakdown of academic impact, for papers by Adam Linder Breakdown of academic impact, for papers by Michael Meisner
Rankless by CCL
2026